Ramnik Xavier
CIK: 0001920780
Transaction Breakdown
Open Market Buys (P)0 (0.0%)
High conviction signal
Open Market Sales (S)0 (0.0%)
Position reduction
Option Exercises (M)0 (0.0%)
Derivative conversions
Awards (A)2 (100.0%)
Compensation grants
Other (G, F, J, C, D, …)0 (0.0%)
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Companies & Roles (1)
MLTX
MoonLake Immunotherapeutics
Director
Discretionary Trading P&L
Holdings
About Xavier Ramnik
Xavier Ramnik (SEC CIK 0001920780) files insider reports with the SEC as Director of MoonLake Immunotherapeutics (MLTX).
Signal8 holds 2 ownership filings by Xavier Ramnik, all Form 4s, filed between Jun 9, 2025 and Jun 18, 2026. Those filings report 2 transactions, from Jun 5, 2025 to Jun 17, 2026. Signal8's Form 4 history starts in Sep 2024.
The business address on Xavier Ramnik's filings is in ZUG.
Recent filings by Xavier Ramnik
Other insiders filing for MoonLake Immunotherapeutics (MLTX)
- Reich Kristian, Chief Scientific Officer
- Santos da Silva Jorge, Chief Executive Officer
- Bodenstedt Matthias, Chief Financial Officer
- BVF PARTNERS L P/IL, Director
- Phillips Andrew John, Director
- Loy Spike, Director